PT Kedoya Adyaraya Tbk (RSGK.JK)
IDR 990.0
(-1.0%)
IDR 990.0
(-1.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 14.58 Billion IDR | 21.55% |
| 2022 | 12 Billion IDR | -13.83% |
| 2021 | 13.92 Billion IDR | 8.18% |
| 2020 | 12.87 Billion IDR | 7.22% |
| 2019 | 12 Billion IDR | -6.78% |
| 2018 | 12.88 Billion IDR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 16.59 Billion IDR | 13.77% |
| 2024 Q2 | 14.22 Billion IDR | -14.3% |
| 2024 Q3 | 15.87 Billion IDR | 11.63% |
| 2023 Q1 | 12.15 Billion IDR | 1.24% |
| 2023 Q4 | 14.58 Billion IDR | -5.67% |
| 2023 Q3 | 15.46 Billion IDR | -31.69% |
| 2023 FY | 14.58 Billion IDR | 21.55% |
| 2023 Q2 | 22.63 Billion IDR | 86.3% |
| 2022 Q2 | 11.94 Billion IDR | -2.69% |
| 2022 FY | 12 Billion IDR | -13.83% |
| 2022 Q4 | 12 Billion IDR | 1.15% |
| 2022 Q3 | 11.86 Billion IDR | -0.66% |
| 2022 Q1 | 12.27 Billion IDR | -11.86% |
| 2021 Q3 | 16.54 Billion IDR | 0.0% |
| 2021 FY | 13.92 Billion IDR | 8.18% |
| 2021 Q1 | - IDR | -100.0% |
| 2021 Q2 | - IDR | 0.0% |
| 2021 Q4 | 13.92 Billion IDR | -15.83% |
| 2020 FY | 12.87 Billion IDR | 7.22% |
| 2020 Q4 | 12.87 Billion IDR | 0.0% |
| 2019 FY | 12 Billion IDR | -6.78% |
| 2018 FY | 12.88 Billion IDR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| PT Bundamedik Tbk | 42.19 Billion IDR | 65.432% |
| PT Metro Healthcare Indonesia Tbk | 4.77 Billion IDR | -205.273% |
| PT Medikaloka Hermina Tbk | 117.43 Billion IDR | 87.578% |
| PT Mitra Keluarga Karyasehat Tbk | 81.72 Billion IDR | 82.15% |
| PT Murni Sadar Tbk | 32.12 Billion IDR | 54.597% |
| PT Famon Awal Bros Sedaya Tbk | 54.16 Billion IDR | 73.069% |
| PT Royal Prima Tbk | 54.57 Billion IDR | 73.271% |
| PT Sarana Meditama Metropolitan Tbk | 53.77 Billion IDR | 72.873% |
| PT Siloam International Hospitals Tbk | 203.57 Billion IDR | 92.835% |
| PT Sejahteraraya Anugrahjaya Tbk | 48.94 Billion IDR | 70.194% |